BIOMARIN PHARMACEUTICAL INC Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31)
BIOMARIN PHARMACEUTICAL INC (BMRN) had Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) of $496.05 million as of 2014-06-30, per its 10-Q filed 2014-07-31.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost · last filed 2014-07-31
- 2014-06-30: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $496.05M.
- 2014-03-31: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $499.15M.
- 2013-12-31: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $483.64M.
- 2013-09-30: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $345.86M.
| Period end | Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) | Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) as first filed |
|---|---|---|
| 2014-06-30 | $496.05M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $499.15M 10-Q · filed 2014-05-02 | |
| 2013-12-31 | $483.64M 10-Q · filed 2014-07-31 | |
| 2013-09-30 | $345.86M 10-Q · filed 2013-10-28 | |
| 2013-06-30 | $349.02M 10-Q · filed 2013-07-29 | |
| 2013-03-31 | $371.32M 10-Q · filed 2013-04-29 | |
| 2012-12-31 | $383.27M 10-K · filed 2014-02-26 | $386.01M 10-K · filed 2013-02-26 |
| 2012-09-30 | $351.42M 10-Q · filed 2012-10-29 | |
| 2012-06-30 | $346.82M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $204.81M 10-Q · filed 2012-04-30 | |
| 2011-12-31 | $243.13M 10-K · filed 2013-02-26 | |
| 2010-12-31 | $313.54M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |